{
  "meta": {
    "title": "Development_And_Disorders_Of_Female_Reproductive_Organ_Physiology_Of_Ovulation_And_Menopause",
    "url": "https://brainandscalpel.vercel.app/development-and-disorders-of-female-reproductive-organ-physiology-of-ovulation-and-menopause-ecbf6144.html",
    "scrapedAt": "2025-11-30T08:49:38.818Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Swyer syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old female presents with primary amenorrhea and normal secondary sexual characteristics. On pelvic examination, there is no palpable uterus, and ultrasound confirms the absence of the uterus and upper two-thirds of the vagina. The ovaries are present and appear normal. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289443",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120600040a0c-f71e-4a44-b41e-34b03b4c55f5.jpg\">\r\n<p><strong>OPTION a) Turner syndrome</strong> is characterized by a single X chromosome (45,X) and typically presents with features such as short stature, webbed neck, and lack of secondary sexual characteristics. <strong>The absence of the uterus and normal ovaries would be inconsistent with Turner syndrome</strong>, where ovarian failure leads to primary amenorrhea but the uterus is usually present.</p>\r\n<p><strong>OPTION b) Androgen insensitivity syndrome</strong>: This condition involves a male karyotype (46,XY) with a mutation in the androgen receptor gene, resulting in a female phenotype with normal secondary sexual characteristics but lack of a functional uterus and upper vagina. However, <strong>the patient in this case has normal ovaries, which is inconsistent with androgen insensitivity syndrome, where the testes are present but not functional.</strong></p>\r\n<p><strong>OPTION c) Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome</strong> is characterized by the <strong>congenital absence of the uterus and the upper two-thirds of the vagina with normal ovarian function</strong>. Individuals with MRKH syndrome have normal secondary sexual characteristics due to functional ovaries, which aligns with the presentation in the question.</p>\r\n<p><strong>OPTION d) Swyer syndrome</strong> involves a 46,XY karyotype with a nonfunctional gonadal development leading to a female phenotype with a <strong>lack of secondary sexual characteristics</strong>. It usually presents with streak ovaries, absent or poorly developed uterus, and lack of menstruation. However, this does not fit with the normal ovaries and secondary sexual characteristics described in the case.</p>\r\n<p><strong>KEY TAKE AWAY - Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome is the most likely diagnosis given the absence of the uterus and upper two-thirds of the vagina while having normal secondary sexual characteristics and ovarian appearance.</strong></p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter syndrome</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen Insensitivity Syndrome</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Swyer syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A mutation in the SRY gene can lead to which of the following conditions?</span></p>",
      "unique_key": "DT1289450",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Swyer syndrome, also known as 46,XY gonadal dysgenesis, is a condition where individuals have a Y chromosome but a nonfunctional SRY gene, leading to the development of a female phenotype despite having a male genotype.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206df3805a1-9dd7-473f-8f53-86d2a0b2b55e.jpg\">\r\n<p><strong>OPTION A:</strong> Turner syndrome is characterized by the presence of a single X chromosome (45,X) and is associated with short stature, webbed neck, and gonadal dysgenesis (streak ovaries). It is not caused by a mutation in the SRY gene, but rather by the absence of a second sex chromosome.</p>\r\n<p><strong>OPTION B: </strong>Klinefelter syndrome typically involves an extra X chromosome in males (47,XXY) and results in features such as gynecomastia and infertility. It is not caused by an SRY gene mutation but is due to chromosomal abnormalities affecting the sex chromosomes.</p>\r\n<p><strong>OPTION C: Androgen Insensitivity Syndrome</strong> is caused by mutations in the androgen receptor gene, leading to a 46,XY karyotype with a female phenotype due to the body's inability to respond to androgens. It is not related to SRY gene mutations.</p>\r\n<p><strong>KEY TAKE AWAY</strong>- Swyer syndrome-Non functional SRY gene with female phenotype despite having male genotype (46xy)</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Scrotum & Labia majora</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Penis & Clitoris</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Cowper's gland & Skene's tubules</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Testis & Ovary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are correctly matched with homologous structures in males & females, except:</span></p>",
      "unique_key": "DT1289457",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011807951dd9-bc73-422a-8236-747cda0a6701.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120666a34057-8309-4331-a187-bb99499620ad.jpg\">\r\n<p><strong>KEY TAKE AWAY - Cowper's gland in male is homologus to bartholin's gland in female.</strong></p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Urogenital sinus</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Wolffian ducts</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian ducts</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Genital ridge</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which structure contributes to the formation of lower 1/3rd of vagina?</span></p>",
      "unique_key": "DT1289460",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289460,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The upper two-thirds of the vagina is derived from the M&uuml;llerian ducts (paramesonephric ducts), while the lower one-third is derived from the urogenital sinus.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206d797bff7-c502-46e0-8ed0-f0d5c0a1391e.jpg\">\r\n<p><strong>OPTION a) Urogenital sinus</strong></p>\r\n<p>The lower one-third of the vagina develops from the urogenital sinus, which is part of the embryonic development of the female reproductive tract. The urogenital sinus contributes to the formation of the lower vagina, while the upper two-thirds of the vagina develop from the M&uuml;llerian ducts.</p>\r\n<p><strong>OPTION b) Wolffian ducts</strong>: These ducts are involved in the development of the male reproductive tract and degenerate in females. They do not contribute to the formation of the vagina.</p>\r\n<p><strong>OPTION c) M&uuml;llerian ducts</strong>: These ducts are responsible for forming the upper two-thirds of the vagina, as well as the uterus and fallopian tubes. They do not contribute to the lower one-third of the vagina.</p>\r\n<p><strong>OPTION d) Genital ridge</strong>: This structure is involved in the formation of the gonads (ovaries or testes) but does not contribute directly to the formation of the vagina.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206a24abd6d-421f-48bd-9be5-6a61e5a21064.jpg\">\r\n<p><strong>KEY TAKE AWAY -</strong> upper 2/3rd of vagina derived from- M&uuml;llerian ducts</p>\r\n<p>Lower1/3rd of vagina derived from - urogenital sinus.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal septum</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical stenosis</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old girl presents with severe pelvic pain and a palpable abdominal mass. She has not started menstruating. On examination, a bulging hymen is observed. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289463",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289463,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>b) Imperforate hymen -This condition occurs when the hymen does not have an appropriate opening, which can obstruct menstrual flow.</p>\r\n<p><strong><u>Explanation:</u></strong><strong> symptoms</strong></p>\r\n<p><strong>abdominal pain-</strong>Pain that occurs regularly, often around the time of menstruation.</p>\r\n<p><strong>Bloating and discomfort-</strong>Feeling full or swollen, often accompanied by pain or discomfort.</p>\r\n<p><strong>Mass in the lower abdomen-</strong>A palpable lump or swelling in the lower part of the abdomen.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412068d8a0ed8-0302-4e9e-8458-481d5ad98fb0.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120623e64b11-cf9f-48aa-b3fb-2b2e90aa5241.jpg\">\r\n<p><strong>OPTION A: Vaginal septum</strong> can cause similar symptoms but typically presents with a different set of findings, such as difficulty with tampon use or recurrent infections. It would not usually present with a bulging hymen and is less commonly associated with acute severe pain.</p>\r\n<p><strong>OPTION B: Imperforate hymen</strong>: This condition occurs when the hymen does not have an appropriate opening, which can obstruct menstrual flow.</p>\r\n<p><strong>OPTION C: Cervical stenosis</strong> can lead to menstrual problems but would not usually present with a bulging hymen. It is less likely to cause the same acute symptoms and abdominal mass seen in imperforate hymen.</p>\r\n<p><strong>OPTION D: M&uuml;llerian anomalies</strong> involve abnormalities in the development of the uterus, cervix, or vagina and might present with irregular menstrual bleeding or pelvic pain but typically do not cause a bulging hymen.</p>\r\n<p><strong>KEY TAKE AWAY - Bluish bulging hymen with cyclical pain abdomen with no h/o of Menarche suggestive of imperforate hymen.</strong></p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete Androgen Insensitivity Syndrome </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner Syndrome </span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian Agenesis </span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital Adrenal Hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 13-year-old girl with primary amenorrhea has a normal external genitalia and normal breast development. She presents with a lack of menstrual bleeding and a short vagina. Karyotyping shows 46,XX. What is the most probable diagnosis? </span></p>",
      "unique_key": "DT1289480",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289480,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Mullerian Agenesis (or Mayer-Rokitansky-K&uuml;ster-Hauser syndrome) is consistent with a 46,XX karyotype and involves the absence or underdevelopment of the uterus and upper two-thirds of the vagina.</strong> This condition explains the primary amenorrhea, normal external genitalia, normal breast development, and a short vagina.</p>\r\n<p><strong>OPTION A: Complete Androgen Insensitivity Syndrome (CAIS) would typically present with a 46,XY karyotype, not 46,XX.</strong> In CAIS, individuals have normal female external genitalia. and does not menstruate.</p>\r\n<p><strong>OPTION B: Turner Syndrome is characterized by a 45,X karyotype, not 46,XX.</strong> Common features include short stature, webbed neck, and ovarian failure. Turner Syndrome usually involves some degree of physical anomalies and would not present with normal breast development and external genitalia in the way described.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412066bbf8e9a-fae7-44e0-a2b3-868e8224cbea.jpg\">\r\n<p><strong>OPTION D: </strong>Congenital Adrenal Hyperplasia (CAH) usually results in excess androgen production and can cause <strong>ambiguous genitalia or virilization.</strong> It would not typically present with normal external genitalia and normal breast development in a 46,XX individual.</p>\r\n<p><strong>KEY TAKEAWAY: </strong></p>\r\n<p>Classical presentation of Mullerian agenesis</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120643705a9f-8b62-4fa6-8763-56452e01fa2a.jpg\">",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner Syndrome </span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen Insensitivity Syndrome </span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter Syndrome </span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian Agenesis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old girl presents with primary amenorrhea and normal breast development. On examination, she has a normal female external genitalia but a short vagina. Karyotyping reveals a 46,XY karyotype. What is the most likely diagnosis? </span></p>",
      "unique_key": "DT1289481",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289481,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206778626eb-3a13-450a-8108-99daf040d4e4.jpg\">\r\n<p><strong>OPTION A:</strong> Turner Syndrome is characterized by a 45,X karyotype (monosomy X) or other chromosomal abnormalities involving the X chromosome. It typically presents with primary amenorrhea, short stature, and a range of other physical abnormalities, but it would not present with a 46,XY karyotype or normal breast development. The external genitalia are usually normal.</p>\r\n<p><strong>OPTION B: Androgen Insensitivity Syndrome (AIS) is a condition where individuals have a 46,XY karyotype </strong>but are resistant to androgens (male hormones). As a result, individuals develop normal female external genitalia and secondary sexual characteristics (such as breast development) despite having testes and a male chromosomal pattern. The vagina may be short or absent due to the underdevelopment of M&uuml;llerian structures, which is consistent with the patient's presentation of primary amenorrhea, normal breast development, and a short vagina.</p>\r\n<p><strong>OPTION C: Klinefelter Syndrome is characterized by a 47,XXY karyotype</strong> or other variations involving extra sex chromosomes. It typically affects males and presents with features such as reduced testosterone levels, infertility, and gynecomastia.</p>\r\n<p><strong>OPTION D:</strong> M&uuml;llerian Agenesis (MRKH syndrome) involves the absence or underdevelopment of the uterus and upper two-thirds of the vagina in individuals with a normal 46,XX karyotype. <strong>The presence of a 46,XY karyotype rules out M&uuml;llerian Agenesis</strong>, making it an unlikely diagnosis in this case.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: The most likely diagnosis is Androgen Insensitivity Syndrome. This condition explains the 46,XY karyotype, normal external female genitalia, normal breast development, and a short or absent vagina.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital Adrenal Hyperplasia </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen Insensitivity Syndrome </span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner Syndrome </span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian Agenesis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl with a history of primary amenorrhea has an elevated serum testosterone level. Physical examination reveals normal external genitalia but increased body hair and acne. Karyotyping shows 46,XX. What is the most likely diagnosis? </span></p>",
      "unique_key": "DT1289489",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289489,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Congenital Adrenal Hyperplasia is characterized by an enzyme deficiency that leads to an overproduction of androgens by the adrenal glands. <strong>This condition can cause elevated serum testosterone levels, which results in symptoms like increased body hair (hirsutism) and acne. Primary amenorrhea in the context of CAH is due to the hormonal imbalance affecting the menstrual cycle. The 46,XX karyotype indicates that the individual is genetically female, which aligns with CAH</strong>, as it does not affect the chromosomal sex.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206b306b726-b0c6-44f9-bcd7-5ae757c7a09b.jpg\">\r\n<p><strong>OPTION B: Androgen Insensitivity Syndrome is a condition where individuals with a 46,XY karyotype</strong> are resistant to androgens. This leads to normal external female genitalia despite the presence of male chromosomes. Symptoms include a lack of menstruation and normal breast development, but with an elevated serum testosterone, this is not the correct diagnosis for a 46,XX individual.</p>\r\n<p><strong>OPTION C: </strong>Turner Syndrome (45,X) is associated with features such as short stature and primary amenorrhea due to ovarian dysgenesis. <strong>Elevated testosterone and increased body hair are not typical features of Turner Syndrome. The karyotype would typically be 45,X or other variants rather than 46,XX.</strong></p>\r\n<p><strong>OPTION D: </strong>M&uuml;llerian Agenesis involves the absence of the uterus and the upper part of the vagina, leading to primary amenorrhea. It does not usually present with elevated serum testosterone or symptoms like increased body hair and acne. Raised testosterone levels make M&uuml;llerian Agenesis an unlikely diagnosis.</p>\r\n<p>KEY TAKEAWAY: <strong>The most likely diagnosis is Congenital Adrenal Hyperplasia (CAH) due to the elevated serum testosterone, increased body hair, and acne, consistent with androgen excess, and a normal 46,XX karyotype.</strong></p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner Syndrome</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter Syndrome</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen Insensitivity Syndrome</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian Agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man presents with primary infertility and reduced secondary sexual characteristics. He is exceptionally tall, and physical examination reveals gynecomastia and small testes. Karyotyping shows 47,XXY karyotype. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289493",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289493,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Klinefelter Syndrome is characterized by a 47,XXY karyotype and presents with features like tall stature, gynecomastia, small testes, and infertility. This diagnosis is consistent with the patient's karyotype and symptoms.</strong></p>\r\n<p><strong>OPTION A:</strong> <strong>Turner Syndrome is characterized by a 45,X karyotype and is seen in females.</strong> It is associated with features like short stature and ovarian dysgenesis, which do not match the presentation of a male with a 47,XXY karyotype.</p>\r\n<p><strong>OPTION C: Androgen Insensitivity Syndrome is typically associated with a 46,XY karyotype</strong> and involves resistance to androgens, leading to female external genitalia in a genetically male individual. The patient's 47,XXY karyotype and symptoms are not consistent with this condition.</p>\r\n<p><strong>OPTION D: </strong>M&uuml;llerian Agenesis involves the absence of the uterus and part of the vagina and does not affect the karyotype (46 XX) or present with the features described in the case.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206bf05616d-af29-4ca9-80cd-50ff20b4de1e.jpg\">",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous conception </span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Egg donation and IVF</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian tissue cryopreservation</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine transplantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman with Turner Syndrome is seeking fertility treatment. USG shows bilateral streak ovaries. Her labs shows very low AMH & elevated FSH levels. What is the most appropriate recommendation for her to achieve pregnancy?</span></p>",
      "unique_key": "DT1289497",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Egg donation combined with IVF is the most appropriate recommendation for women with Turner Syndrome and primary ovarian insufficiency (as evidenced by low AMH &amp; high FSH levels). </strong>Since these women typically have primary ovarian insufficiency and do not produce viable eggs, using donor eggs and undergoing IVF allows them to achieve pregnancy.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120680ee5cda-62c7-4dad-a57a-42f499af94e2.jpg\">\r\n<p><strong>OPTION A: </strong>Natural conception is generally not viable for women with Turner Syndrome as their streak ovaries typically do not produce functional eggs. Therefore, this option is not suitable.</p>\r\n<p><strong>OPTION C: </strong>Ovarian tissue cryopreservation is a method used to preserve ovarian function for future use, but it is not effective for women who already have primary ovarian insufficiency (as in this case), as the ovarian tissue is unlikely to be functional.</p>\r\n<p><strong>OPTION D: </strong>Uterine transplantation is still experimental and involves significant risks and complexity.</p>\r\n<p><strong>KEY TAKEAWAY: Egg donation combined with IVF is the most practical and effective approach for achieving pregnancy in women with Turner Syndrome who have impaired ovarian function.</strong></p>\r\n<p><a href=\"http://www.researchgate.com\">www.researchgate.com</a></p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Luteinizing hormone (LH)</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicle-stimulating hormone (FSH)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During the menstrual cycle, which hormone is primarily responsible for triggering ovulation?</span></p>",
      "unique_key": "DT1289500",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289500,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>OPTION A: Estrogen promotes the growth of ovarian follicles but <strong>does not trigger ovulation directly.</strong></p>\r\n<p>OPTION B: Progesterone is secreted after ovulation to maintain the endometrial lining.</p>\r\n<p>OPTION C: Luteinizing hormone (LH) surge triggers ovulation.</p>\r\n<p>OPTION D: Follicle-stimulating hormone (FSH) stimulates follicle growth but not ovulation.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206d796ec22-f3d8-4086-bc47-bdcef6167bdb.jpg\">",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a decapeptide</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">It is synthesized in the supraoptic nucleus of hypothalamus</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">It has a half-life of 2-4 minutes</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">The pulsatility & amplitude of its release varies with different phases of menstrual cycle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements are correct regarding GnRH, except:</span></p>",
      "unique_key": "DT1289506",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289506,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Let's break down each statement regarding Gonadotropin-Releasing Hormone (GnRH) to determine which one is incorrect:</p>\r\n<p>OPTION A:</p>\r\n<ul>\r\n<li>Correct: <strong>GnRH is indeed a decapeptide</strong>, which means it is composed of 10 amino acids.</li>\r\n</ul>\r\n<p>OPTION B:</p>\r\n<ul>\r\n<li>Incorrect: <strong>GnRH is synthesized in the arcuate nucleus of the hypothalamus, not the supraoptic nucleus. </strong>The supraoptic nucleus primarily produces antidiuretic hormone (ADH) and oxytocin.</li>\r\n</ul>\r\n<p>OPTION C:</p>\r\n<ul>\r\n<li>Correct: <strong>GnRH has a very short half-life of about 2-4 minutes</strong>, which allows for its precise regulation through pulsatile release.</li>\r\n</ul>\r\n<p>OPTTION D:</p>\r\n<ul>\r\n<li>Correct: <strong>The release of GnRH is pulsatile and its frequency and amplitude vary with different phases of the menstrual cycle.</strong> This variation is crucial for the regulation of the menstrual cycle and the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).</li>\r\n</ul>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<p>Gonadotropin-Releasing Hormone (GnRH) plays a crucial role in the initiation of puberty. Interestingly, the pulsatile release of GnRH during puberty is essential for the activation of the hypothalamic-pituitary-gonadal (HPG) axis. These hormones subsequently stimulate the gonads (ovaries in females and testes in males) to produce sex hormones, leading to the development of secondary sexual characteristics and the onset of reproductive capability.</p>\r\n<p>The \"rhythm\" of GnRH release during puberty essentially \"switches on\" the entire reproductive system!</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Menopause </span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">PCOS </span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Premature Ovarian Insufficiency </span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Oophorectomy </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">High levels of AMH are seen in:</span></p>",
      "unique_key": "DT1289508",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289508,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>OPTION A: <strong>AMH levels are typically low or undetectable in menopause</strong> due to the depletion of ovarian follicles.</p>\r\n<p>OPTION B: <strong>High levels of AMH are commonly observed in PCOS</strong> because of the increased number of small follicles (antral follicles) in the ovaries. AMH is secreted by these follicles, so elevated levels are seen in this condition.</p>\r\n<p>OPTION C: <strong>AMH levels are generally low in POI</strong> due to a reduced number of ovarian follicles.</p>\r\n<p>OPTION D<strong>: Oophorectomy, or removal of the ovaries, results in very low or undetectable levels of AMH </strong>since the ovaries are the primary source of AMH production.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206aec2e820-ba00-4ee6-8c78-a1df2eb3e95c.jpg\">",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Deviation from the typical 28-day menstrual cycle typically occurs because of different lengths in the follicular phases</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Although one oocyte is typically ovulated per cycle, several will begin their development</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">prolonged elevations in progesterone levels trigger the LH surge</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">During menstruation thromboxane and prostaglandin homeostasis control myometrial and vascular contractions in the uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is FALSE ?</span></p>",
      "unique_key": "DT1289514",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289514,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Prolonged elevations in estrogen, not progesterone, triggers the LH surge.</strong> Prolonged elevations of progesterone suppress FSH and thus the next menstrual cycle (consider that pregnancy results in elevated progesterone levels, maintaining the endometrium and suppressing ovulation).</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206875ff3fe-c5a0-4d06-8162-1e8579887095.jpg\">\r\n<p>OPTION A: <strong>Variation in the typical 28-day cycle is due to differences in the length of the follicular phase</strong>, whereas the luteal phase is relatively standard at 14 &plusmn; 2 days.</p>\r\n<p>OPTION B: Although there is only one Graafian or dominant follicle ovulated per cycle, a whole cohort of early stage ovarian follicles develop at the beginning of each menstrual cycle. This cohort of selected follicles likely began to develop several months/cycles prior to the cycle of their ultimate selection.</p>\r\n<p>OPTION D: <strong>Thromboxane and prostaglandin-mediated myometrial and vascular contractions</strong> result in ischemia and endometrial sloughing at the end of a menstrual cycle.</p>\r\n<p><strong>KEY TAKEAWAY:</strong> The critical estradiol level required for the luteinizing hormone (LH) surge to trigger ovulation typically falls within the range of <strong>200-300 pg/mL</strong>. This critical level is important as it signals the peak of estradiol necessary to initiate the LH surge, which is a key trigger for ovulation in the menstrual cycle.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum progesterone levels </span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum estradiol levels </span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum FSH levels </span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">LH surge detection in urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests can be used to confirm ovulation? </span></p>",
      "unique_key": "DT1289518",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289518,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Serum progesterone levels are a reliable marker for confirming ovulation.</strong> After ovulation, the corpus luteum produces progesterone, which increases serum levels. High progesterone levels in the luteal phase indicate that ovulation has occurred.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120681a9c4ff-b46f-49f9-90d9-163566131cf9.jpg\">\r\n<p>OPTION B: While serum <strong>estradiol levels can provide information about follicle development and maturation, they are not as definitive for confirming ovulation</strong> as progesterone levels. Estradiol peaks before ovulation but does not confirm that ovulation has occurred.</p>\r\n<p>OPTION C: Serum FSH (Follicle-Stimulating Hormone) levels are useful for <strong>evaluating ovarian reserve and function but do not directly confirm ovulation.</strong> FSH levels are higher at the start of the cycle and decrease after follicle maturation and ovulation.</p>\r\n<p>OPTION D: <strong>LH (Luteinizing Hormone) surge detection in urine can indicate that ovulation is imminent, but it does not confirm that ovulation has actually occurred. </strong>It shows the LH surge, which triggers ovulation, but the actual release of the egg needs to be confirmed through other means like progesterone levels or ultrasound.</p>\r\n<p><strong>KEY TAKEAWAY:</strong> Serum progesterone level is a reliable test for confirming ovulation because they directly reflect the hormonal changes that occur after the release of the egg.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">FSH</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Estradiol</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">AHM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57 year old woman has not had menses for more than last 12 months. All of the following hormones would have diminished serum levels, except: </span></p>",
      "unique_key": "DT1289521",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289521,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Few years prior to menopause, along with depletion of the ovarian follicles, the follicles become resistant to pituitary gonadotropins. As a result, <em>effective folliculogenesis is impaired with diminished estradiol production.</em> There is a <strong>significant fall in the serum level of estradiol</strong> from 50-300 pg/mL before menopause to 10-20 pg/mL after menopause.</p>\r\n<p>OPTION A: Decrease in serum estradiol</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206234a0c03-d09c-45fd-8dbb-2a44061748e7.jpg\">\r\n<p><em>Negative feedback on hypothalamus-pituitary axis decreases</em></p>\r\n<p>Increase in GnRH (Gonadotropin-releasing hormone) secretion</p>\r\n<p>Increase in FSH (Follicle-stimulating hormone) secretion</p>\r\n<p>Diminished inhibin (a hormone produced by ovarian follicles)</p>\r\n<p>Further increase in FSH secretion</p>\r\n<p>OPTION B: <strong>Inhibin</strong>, a peptide, is secreted by the granulosa cells of the ovarian follicle, <strong>decreases after menopause</strong>.</p>\r\n<p>OPTTION D: <em>AMH is secreted by the granulosa cells</em>. <strong>Levels of AMH decrease progressively</strong> during the menopause transition.</p>\r\n<p><strong><em>KEY TAKEAWAY:</em></strong> <strong><em>Elevated FSH levels are a hallmark of menopause and are often used diagnostically to confirm the transition into menopause.</em></strong></p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrone (E1)</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Estradiol (E2)</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Estriol (E3)</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Estetrol (E4)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year old woman is menopausal since 2 years. Which of the following forms of estrogen will be the most abundant in the serum of this woman?</span></p>",
      "unique_key": "DT1289526",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289526,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412063e615710-811e-48b2-b43b-43a4292e1046.jpg\">\r\n<p>OPTION A: <strong>Estrone</strong> is the primary form of estrogen after menopause. It is produced mainly in adipose tissue from androstenedione and has weaker estrogenic activity compared to estradiol.</p>\r\n<p>OPTION B: <strong><em>Estradiol</em></strong><em> is the most potent and abundant estrogen during the reproductive years. It is produced by the ovaries</em> and is responsible for the regulation of the menstrual cycle, <em>development of secondary sexual characteristics, </em>and maintenance of reproductive tissues.</p>\r\n<p>OPTION C: <strong><em>Estriol </em></strong><em>is the predominant estrogen during pregnancy, </em>produced in large quantities <em>by the placenta</em>. It has a weaker estrogenic effect compared to estradiol but plays a crucial role in maintaining pregnancy and preparing the body for childbirth.</p>\r\n<p>OPTION D: <strong><em>Estetrol (E4)</em></strong><em> is a naturally occurring estrogen</em> produced <em>exclusively by the fetal liver during pregnancy.</em> It is one of the lesser-known estrogens compared to estradiol (E2), estrone (E1), and estriol (E3), but it has unique properties and potential clinical applications e.g. use in HRT.</p>\r\n<p><strong><em>KEY TAKEAWAY: </em></strong></p>\r\n<p>Mnemonic to remember the different forms of estrogen and the life stages they are most abundant in:</p>\r\n<p><strong>\"E1, E2, E3, E4 - Menopause, Woman's Core, Pregnant More, Fetus Galore!\"</strong></p>\r\n<ul>\r\n<li><strong>E1 (Estrone)</strong> - <strong>Menopause</strong>: The primary estrogen after menopause.</li>\r\n<li><strong>E2 (Estradiol)</strong> - <strong>Woman's Core</strong>: Dominant during the <strong>reproductive years</strong>.</li>\r\n<li><strong>E3 (Estriol)</strong> - <strong>Pregnant More</strong>: The key estrogen during <strong>pregnancy</strong>.</li>\r\n<li><strong>E4 (Estetrol)</strong> - <strong>Fetus Galore</strong>: Produced by the <strong>fetus</strong> during pregnancy.</li>\r\n</ul>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait & Watch </span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormone replacement therapy</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial biopsy</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57 year old postmenopausal woman is found to have an endometrial thickness of 7 mm on ultrasound. What is the next best step in management?</span></p>",
      "unique_key": "DT1289531",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>An endometrial thickness of more than 4-5 mm in a postmenopausal woman warrants further investigation to <em>rule out endometrial hyperplasia or carcinoma.</em></p>\r\n<p>OPTION A: In postmenopausal women, an endometrial thickness (ET) greater than 4 mm on transvaginal ultrasound (USG) is a significant finding and often warrants further evaluation to rule out endometrial pathology.</p>\r\n<p>OPTION B: Before initiating or continuing HRT, <em>an endometrial biopsy is recommended to rule out endometrial hyperplasia or carcinoma, </em>especially if the patient has an ET of 7 mm. This is crucial to ensure that there is no underlying pathology that needs treatment.</p>\r\n<p>OPTION D: Before considering a hysterectomy, an endometrial biopsy is essential to evaluate the cause of the increased ET. This step is crucial to rule out or confirm the presence of endometrial hyperplasia or carcinoma. <em>A hysterectomy is typically not required if the biopsy is normal </em>and there are no other indications for surgery.</p>\r\n<p><strong><em>KEY TAKEAWAY:</em></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412068c8cf196-f03f-4cb1-ab3c-610f1e12b3b2.jpg\">\r\n<p><strong><em>In postmenopausal women, an endometrial thickness (ET) greater than 4 mm on transvaginal ultrasound (USG) typically warrants further evaluation with an endometrial biopsy.</em></strong></p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen replacement therapy</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">SERMs </span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide  </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the recommended first-line treatment for a postmenopausal woman with osteoporosis and a history of vertebral fractures?</span></p>",
      "unique_key": "DT1289533",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Bisphosphonates (e.g., Alendronate, Risedronate, Ibandronate, Zoledronic Acid<br /> <strong><u>Explanation:</u></strong> Bisphosphonates are recommended as a first-line treatment for postmenopausal women with osteoporosis and vertebral fractures due to their effectiveness in reducing fracture risk.</p>\r\n<p><strong>Alternative Options but not first line:</strong> SERMs (OPTION B), Teriparatide (OPTION D) Denosumab, HRT (OPTION A)</p>\r\n<p><strong><em>KEY TAKEAWAY:</em></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412063d606de0-20a3-42b7-aa0a-53e133e06e58.jpg\">",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Tibolone</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Ospemifene</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Danazol </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following drugs can be used to treat menopausal symptoms, except: </span></p>",
      "unique_key": "DT1289537",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><u></u>OPTION A: <strong><em>Tibolone</em></strong><em> is a synthetic steroid used in hormone replacement therapy (HRT) for menopausal women.</em></p>\r\n<p><strong>Mechanism of Action:</strong></p>\r\n<ul>\r\n<li><strong>Estrogenic Effects:</strong> Tibolone has estrogen-like effects on bone, which helps prevent osteoporosis.</li>\r\n<li><strong>Progestogenic Effects:</strong> It has progestogen-like effects that help in reducing the risk of endometrial hyperplasia.</li>\r\n<li><strong>Androgenic Effects:</strong> It has mild androgenic effects that can improve libido and mood.</li>\r\n</ul>\r\n<p>OPTION B: <strong>Ospemifene</strong> is primarily used for the treatment of moderate to severe <strong>vulvar and vaginal atrophy (VVA)</strong> associated with menopause. It acts as an <em>estrogen agonist specifically in vaginal tissues. </em>This action helps to restore and <em>maintain the vaginal epithelium, reducing symptoms of atrophy.</em></p>\r\n<p>OPTION C: <strong>Clonidine is sometimes used off-label to manage hot flashes</strong> in menopausal women, especially for those who cannot or prefer not to use hormone replacement therapy (HRT). Clonidine works by stimulating <em>alpha-2 adrenergic receptors in the brain, which reduces sympathetic nervous system activity</em>. This can lead to a <em>reduction in the frequency and severity of hot flashes.</em></p>\r\n<p>OPTION D: <strong>Danazol can induce a temporary menopause-like state</strong> due to <em>its effects on suppressing ovarian function</em>. This can result in <em>symptoms similar to natural menopause,</em> such as hot flashes, vaginal dryness, and mood changes. It is used in management of endometriosis &amp; fibrocystic breast disease.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}